Article

EGFR variant profiles in lung adenocarcinoma from different regions of Brazil: A multi- institutional study using a rapid RT‒PCR platform

2025-05-21

Abstract excerpt

<title>Abstract</title> <p>Background Lung cancer is the second most diagnosed cancer and activating <italic>EGFR</italic> variants are involved in the pathogenesis of a significant subset of lung adenocarcinomas. Given that Brazil is the largest and most populous country in South America with high ancestry’s admixture, this study aimed to evaluate the frequency of the <italic>EGFR</italic> variant and its subty...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 341e59be-65db-5462-8163-7d91f055df53
DOI: 10.21203/rs.3.rs-6606895/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

EGFR variant profiles in lung adenocarcinoma from different regions of Brazil: A multi- institutional study using a rapid RT‒PCR platformDOI 10.21203/rs.3.rs-6606895/v1Read

A regional analysis of epidermal growth factor receptor (EGFR) mutated lung cancer for HSE South.Semantic proximity Read

Clinical significance of EGFR mutation types in lung adenocarcinoma: A multi-centre Korean study.Semantic proximity Read

EGFR Mutation Detection in Brazilian Patients With Non-Small-Cell Lung Cancer: Lessons From Real-World Data Scenario of Molecular Testing.Semantic proximity Read

A multicenter-retrospective study of non-small-cell lung carcinoma harboring uncommon epidermal growth factor receptor (EGFR) mutations: different subtypes of EGFR exon 19 deletion-insertions exhibit the clinical characteristics and prognosis of non-small cell lung carcinomaSemantic proximity Read

Updated incidence of EGFR mutation in Middle Eastern patients with non-small cell lung cancer: a 7-year study in a Lebanese institution.Semantic proximity Read

Mutational Analysis of EGFR Mutations in Non-Small Cell Lung Carcinoma-An Indian Perspective of 212 Patients.Semantic proximity Read

Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation typesSemantic proximity Read

Prevalence of EGFR Mutations in Patients With Resected Stages I to III NSCLC: Results From the EARLY-EGFR Study.Semantic proximity Read

EGFR mutation spectrum and clinical correlations in Tunisian Non-Small cell lung cancer patients.Semantic proximity Read

Molecular epidemiology and clinical characteristics of epidermal growth factor receptor mutations in NSCLC: A single-center experience from India.Semantic proximity Read

Mutational profile of Brazilian lung adenocarcinoma unveils association of EGFR mutations with high Asian ancestry and independent prognostic role of KRAS mutationsSemantic proximity Read

Divergent epidermal growth factor receptor mutation patterns between smokers and non-smokers with lung adenocarcinoma.Semantic proximity Read